Erudio Healtherudio.com
Sponsor
Memorial Sloan Kettering Cancer Center trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Memorial Sloan Kettering Cancer Center yet. Erudio has found public clinician commentary on 22 clinical trials sponsored by Memorial Sloan Kettering Cancer Center, including NCT04165772, NUTRIVENTION-3, NUTRIVENTION5 and OPRA. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Memorial Sloan Kettering Cancer Center). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| OPRA NCT02008656 · Memorial Sloan Kettering Cancer Center DeepView → | locally advanced rectal cancer | Phase 2 | Deep | View | |||
| NUTRIVENTION-3 NCT05640843 · Memorial Sloan Kettering Cancer Center DeepView → | MGUS or smoldering multiple myeloma | Not applicable | Deep | View | |||
| NUTRIVENTION5 NCT07226609 · Memorial Sloan Kettering Cancer Center StandardView → | newly diagnosed multiple myeloma | Not applicable | Standard | View | |||
| NCT04165772 NCT04165772 · Memorial Sloan Kettering Cancer Center FocusedView → | locally advanced mismatch repair-deficient solid tumors | Phase 2 | Focused | View | |||
| NUTRIVENTION-4 NCT04497961 · Memorial Sloan Kettering Cancer Center FocusedView → | multiple myeloma | Phase 2 | Focused | View | |||
| STARLITE-2 NCT05239533 · Memorial Sloan Kettering Cancer Center FocusedView → | advanced clear cell renal cell carcinoma | Phase 2 | Focused | View | |||
| NCT02538198 NCT02538198 · Memorial Sloan Kettering Cancer Center FocusedView → | multiple myeloma | Phase 2 | Focused | View | |||
| NCT04410796 NCT04410796 · Memorial Sloan Kettering Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT05912244 NCT05912244 · Memorial Sloan Kettering Cancer Center FocusedView → | untreated unresectable stage III/IV melanoma | Phase 2 | Focused | View | |||
| PSMACare NCT01140373 · Memorial Sloan Kettering Cancer Center FocusedView → | castrate metastatic prostate cancer | Phase 1 | Focused | View | |||
| NCT03618550 NCT03618550 · Memorial Sloan Kettering Cancer Center FocusedView → | relapsed or refractory classical Hodgkin lymphoma | Phase 2 | Focused | View | |||
| NCT01639508 NCT01639508 · Memorial Sloan Kettering Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT03832569 NCT03832569 · Memorial Sloan Kettering Cancer Center FocusedView → | Not given | Early phase 1 | Focused | View | |||
| NCT04161755 NCT04161755 · Memorial Sloan Kettering Cancer Center FocusedView → | surgically resected pancreatic cancer | Phase 1 | Focused | View | |||
| NCT04965090 NCT04965090 · Memorial Sloan Kettering Cancer Center FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT05126472 NCT05126472 · Memorial Sloan Kettering Cancer Center FocusedView → | Not given | Phase 1/Phase 2 | Focused | View | |||
| NCT03290950 NCT03290950 · Memorial Sloan Kettering Cancer Center FocusedView → | newly diagnosed multiple myeloma | Phase 2 | Focused | View | |||
| NCT03635892 NCT03635892 · Memorial Sloan Kettering Cancer Center FocusedView → | advanced or metastatic non-clear cell renal cell carcinoma | Phase 2 | Focused | View | |||
| NCT04162015 NCT04162015 · Memorial Sloan Kettering Cancer Center FocusedView → | resectable malignant pleural mesothelioma | Phase 1 | Focused | View | |||
| GemBCG NCT04179162 · Memorial Sloan Kettering Cancer Center FocusedView → | BCG-relapsing high-grade non-muscle-invasive bladder cancer | Phase 1/Phase 2 | Focused | View | |||
| SAABR NCT04262154 · Memorial Sloan Kettering Cancer Center FocusedView → | newly diagnosed hormone-sensitive metastatic prostate cancer | Phase 2 | Focused | View | |||
| NCT05607095 NCT05607095 · Memorial Sloan Kettering Cancer Center FocusedView → | Not given | Phase 1 | Focused | View | |||